Page last updated: 2024-09-04

cryptotanshinone and Dermatitis, Atopic

cryptotanshinone has been researched along with Dermatitis, Atopic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boldbaatar, A; Buyanravjikh, S; Han, S; Jeong, AL; Ka, HI; Lee, MS; Lee, S; Lim, JS; Park, JY; Yang, Y	1

Other Studies

1 other study(ies) available for cryptotanshinone and Dermatitis, Atopic

Article	Year
Cryptotanshinone inhibits IgE‑mediated degranulation through inhibition of spleen tyrosine kinase and tyrosine‑protein kinase phosphorylation in mast cells. Molecular medicine reports, 2018, Volume: 18, Issue:1 Topics: Animals; Cell Degranulation; Cell Line, Tumor; Dermatitis, Atopic; Immunoglobulin E; Interleukin-1beta; Male; Mast Cells; Mice; Mice, Inbred BALB C; Phenanthrenes; Phosphorylation; Rats; Syk Kinase; Tumor Necrosis Factor-alpha	2018

Article

Year

Cryptotanshinone inhibits IgE‑mediated degranulation through inhibition of spleen tyrosine kinase and tyrosine‑protein kinase phosphorylation in mast cells.

Molecular medicine reports, 2018, Volume: 18, Issue:1

Topics: Animals; Cell Degranulation; Cell Line, Tumor; Dermatitis, Atopic; Immunoglobulin E; Interleukin-1beta; Male; Mast Cells; Mice; Mice, Inbred BALB C; Phenanthrenes; Phosphorylation; Rats; Syk Kinase; Tumor Necrosis Factor-alpha

2018